BioMarin Pharmaceuticals
BMRN
BMRN
377 hedge funds and large institutions have $19.5B invested in BioMarin Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 148 increasing their positions, 110 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11% more funds holding
Funds holding: 341 → 377 (+36)
9% less call options, than puts
Call options by funds: $218M | Put options by funds: $240M
Holders
377
Holding in Top 10
16
Calls
$218M
Puts
$240M
Top Buyers
| 1 | +$777M | |
| 2 | +$178M | |
| 3 | +$146M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$124M |
| 5 |
SC
Sculptor Capital
New York
|
+$74.4M |
Top Sellers
| 1 | -$193M | |
| 2 | -$125M | |
| 3 | -$113M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$87.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$61.4M |